Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are currently approved in the United States and other major markets, and many more continue to enter clinical development at a steady pace. 

IPAK-EDU is grateful to BRMI as this piece was originally published there and is included in this news feed with mutual agreement. Read More